SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-006657
Filing Date
2021-05-10
Accepted
2021-05-10 16:01:31
Documents
3
Period of Report
2021-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20210510x8k.htm 8-K 25584
2 EX-99.1 tmb-20210510xex99d1.htm EX-99.1 206911
3 GRAPHIC tmb-20210510xex99d1002.jpg GRAPHIC 4478
  Complete submission text file 0001558370-21-006657.txt   239959
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 21906966
SIC: 2834 Pharmaceutical Preparations